Our aim was to compare the efficacy and safety of bivalirudin (Biv) versus heparin (Hep) with
or without similar usage rate of glycoprotein IIb/IIIa inhibitors (GPIs) during percutaneous …

Background—Randomized trials show improved outcomes among acute coronary
syndrome patients treated with bivalirudin. The objective of this analysis was to compare …

Previous studies have compared bivalirudin and unfractionated heparin (UFH) plus the
routine use of glycoprotein IIb/IIIa inhibitors. They have demonstrated that bivalirudin can …

OBJECTIVE: This meta-analysis was performed to assess the efficacy and safety of
bivalirudin compared with unfractionated heparin or enoxaparin plus glycoprotein (GP) …

Objectives: The aim of this study was to evaluate the efficacy of various doses of post–
primary percutaneous coronary intervention (PCI) bivalirudin infusion to prevent acute stent …

To assess the efficacy of the direct thrombin inhibitor bivalirudin relative to heparin during
contemporary coronary intervention, 1,056 patients who underwent elective or urgent …

Background Conflicting evidence exists on the efficacy and safety of bivalirudin
administered as part of percutaneous coronary intervention (PCI) in patients with an acute …

Objectives: The purpose of this study was to determine whether, in patients with ST-segment
elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary …

Importance The safety and efficacy of bivalirudin compared with heparin with or without
glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction (AMI) undergoing …

Low/medium-bleeding-risk populations undergoing percutaneous coronary intervention
(PCI) show significantly less bleeding with bivalirudin (BIV) than with unfractionated heparin …